A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Mar 9, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new online program called "Velibra" that aims to help people with anxiety disorders. Specifically, it focuses on those dealing with panic disorder (with or without fear of being in certain places), social anxiety disorder, and generalized anxiety disorder. The goal is to see if this internet-based therapy can effectively support individuals who are currently on a waiting list for other treatments.

To participate, you need to be between the ages of 18 and 65, have a diagnosed anxiety disorder, and be able to understand German well enough to follow the program and answer questions. You also need to have internet access and be willing to give your consent to join the study. However, if you have certain severe mental health conditions or have recently made changes to your anxiety medication, you won't be eligible. If you join, you can expect to engage with the program at your own pace and provide feedback on your experience. This trial represents an exciting opportunity for individuals seeking help for anxiety in a convenient, self-guided format.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder
• • Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires
• • Written informed consent
• • Internet access
• Exclusion Criteria:
• • Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)
• • Acute suicidality
• • Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)